Intrinsic Value of S&P & Nasdaq Contact Us

Curaleaf Holdings, Inc. CURLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.02
+395.1%

Curaleaf Holdings, Inc. (CURLF) generated $140.35M in operating cash flow for fiscal year 2025. After capital expenditures of $64.55M, free cash flow was $75.8M.

Free cash flow margin was 5.9% of revenue. Cash conversion ratio was -0.56x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (51/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was -0.56x suggests some earnings are non-cash items

Overall SharesGrow Score: 47/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
51/100
Proven by this page
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income
Curaleaf Holdings, Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $137.91M$140.35M$162.57M$75.26M$46.4M
Capital Expenditure $-63.95M$-64.55M$-98.15M$-70.3M$-138.36M
Free Cash Flow $73.96M$75.8M$64.42M$5.05M$-91.96M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message